Roche introduces navify Algorithm Suite to optimise patient care

Roche’s navify Algorithm Suite is a single platform offering clinicians access to medical algorithms generating insights to help improve patient care, as well as aiding early diagnosis. The secure digital ecosystem offers lab and hospital one platform to connect medical algorithms, making it easier for physicians to use and adopt the algorithms they need. The platform is designed to be embedded into existing workflow or electronic health/medical records with securely integrated data. 

The first available medical algorithms in the Algorithm Suite focus on identifying patients at risk for some liver and colon cancers. GAAD analyses gender, age in combination with results of two Roche assays Elecsys AFP and Elecsys PIVKA with the intention to aid in the diagnosis of early stage Hepatocellular Carcinoma in patients with chronic liver disease. ColonFlag is a pre-screening algorithm which analyses age, sex, and a recent complete blood count to identify at-risk healthy people for colorectal cancer. 

“As healthcare data is set to grow annually by 36%,4 digital medical algorithms can generate actionable insights which physicians can use to start delivering on the promise of personalised healthcare,” said Moritz Hartmann, Global Head of Roche Information Solutions at Roche Diagnostics. "With navify Algorithm Suite, clinicians can easily order the medical algorithms they need from Roche and other providers to get enhanced insights that improve patient care."

Additional algorithms for lung, cardiac and other diseases are already in the pipeline. The platform is currently available in Europe and Asia-Pacific.